Mucormycosis in hematologic patients.
Livio Pagano(Agostino Gemelli University Polyclinic), A. Del Favero, Laura Corvatta, Luana Fianchi(Università Cattolica del Sacro Cuore), Marco Picardi(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)), Massimo Offidani(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Annamaria Nosari(Unknown), Domenico D’Antonio(Ospedale di Santo Spirito), Anna Candoni(University of Udine), Pietro Martino(Sapienza University of Rome), Corrado Girmenia(Policlinico Umberto I)
PubMed
February 1, 2004
Cited by 294
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
|PubMed|2006|909
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644